Sumesh Kachroo

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 7

Top Topics

Small Cell Lung Cancer

Prognostic Factors

Ejection Fraction

Top Venues

Future oncology (London, England)

Cancer medicine

Journal of comparative effectiveness research

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Santosh Gautam, Sumesh Kachroo, Richard W DeClue, Maxine D Fisher, Anirban Basu
Clinical and utilization outcomes associated with tumor mutational burden in a real-world pan-tumor population. Journal of comparative effectiveness research 10 (10) (2021)
Santosh Gautam, Sumesh Kachroo, Richard W DeClue, Maxine D Fisher, Anirban Basu
Real-world patterns on tumor mutation burden testing in a pan-tumor population. Future oncology (London, England) 17 (15) (2021)
Sumesh Kachroo, Changxia Shao, Kaushal Desai, Jinghua He, Fan Jin, Shuvayu Sen
Association of clinico-genomic characteristics with tumor mutational burden in small cell lung cancer patients. Future oncology (London, England) 17 (4) (2020)
Junji Lin, Santosh Gautam, Nan Hu, Gboyega Adeboyeje, Sumesh Kachroo
Clinical effectiveness outcomes and healthcare resource utilization of patients diagnosed with small-cell lung cancer. Future oncology (London, England) 17 (4) (2020)
Johan Dalén, Karin Luttropp, Axel Svedbom, Christopher M Black, Sumesh Kachroo
Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study. Advances in therapy 37 (9) (2020)
Pascal Claudepierre, Filip Van den Bosch, Piercarlo Sarzi-Puttini, Nathan Vastesaeger, Marinella Govoni, Sumesh Kachroo
Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort. International journal of rheumatic diseases 22 (6) (2019)
Changxia Shao, Jinghua He, Sumesh Kachroo, Fan Jin
Chemotherapy treatments, costs of care, and survival for patients diagnosed with small cell lung cancer: A SEER-Medicare study. Cancer medicine 8 (18) (2019)